BIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICALBIOMARIN PHARMACEUTICAL

BIOMARIN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪290.42 B‬MXN
‪2.85 B‬MXN
‪41.09 B‬MXN
‪185.93 M‬
Beta (1Y)
0.32

About BIOMARIN PHARMACEUTICAL

CEO
Alexander Hardy
Headquarters
San Rafael
Employees (FY)
‪3.4 K‬
Founded
1997
ISIN
US09061G1013
FIGI
BBG00PG3KTG7
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where BMRN is featured.

Frequently Asked Questions

The current price of BMRN is 1575.00 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange BIOMARIN PHARMACEUTICAL stocks are traded under the ticker BMRN.
BIOMARIN PHARMACEUTICAL is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for BIOMARIN PHARMACEUTICAL has a max estimate of 2331.78 MXN and a min estimate of 1332.45 MXN.
BMRN earnings for the last quarter are 3.66 MXN whereas the estimation was 3.86 MXN which accounts for −5.20% surprise. Estimated earnings for the next quarter are 3.32 MXN. See more details about BIOMARIN PHARMACEUTICAL earnings.
BIOMARIN PHARMACEUTICAL revenue for the last quarter amounts to ‪10.13 B‬ MXN despite the estimated figure of ‪10.53 B‬ MXN. In the next quarter revenue is expected to reach ‪10.85 B‬ MXN.
Yes, you can track BIOMARIN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
Like other stocks, BMRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARIN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
BMRN reached its all-time high on Jul 9, 2020 with the price of 2880.00 MXN, and its all-time low was 1287.65 MXN and was reached on Oct 7, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪3.40 K‬ employees. See our rating of the largest employees — is BIOMARIN PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARIN PHARMACEUTICAL EBITDA is ‪5.06 B‬ MXN, and current EBITDA margin is 12.35%. See more stats in BIOMARIN PHARMACEUTICAL financial statements.